Literature DB >> 32881231

LncRNA JPX overexpressed in oral squamous cell carcinoma drives malignancy via miR-944/CDH2 axis.

Yuan Yao1, Shaoshan Chen2, Na Lu1, Yue Yin1, Zhiwen Liu2.   

Abstract

OBJECTIVES: Oral squamous cell carcinoma (OSCC) is a common head and neck cancer with high incidence. Numerous reports have elucidated that long non-coding RNAs (lncRNAs) serve as crucial regulatory factors in various diseases including cancer. Nonetheless, the role of lncRNA JPX in OSCC is still not elaborated. SUBJECTS AND METHODS: In our research, we detected the expression of lncRNA JPX through qRT-PCR. Colony formation, EdU staining, Transwell, TUNEL, and caspase-3 activity assays were applied for estimating the function of lncRNA JPX in OSCC. RIP, pull-down, and luciferase reporter experiments were adopted to examine the interrelations between lncRNA JPX, miR-944, and CDH2.
RESULTS: LncRNA JPX was discovered as highly expressed in OSCC cells. Silencing lncRNA JPX restrained OSCC cell proliferation, migration, and invasion. Interestingly, lncRNA JPX bound with miR-944 and then augmented CDH2 via a competing endogenous RNA (ceRNA) mechanism. Importantly, overexpressed CDH2 recovered the suppression of silenced lncRNA JPX on the oncogenic behaviors of OSCC cells.
CONCLUSIONS: In short, lncRNA JPX contributes to OSCC cell proliferation, migration, and invasion via miR-944/CDH2 axis, which offers a new direction for potential targeted treatment of OSCC.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  CDH2; lncRNA JPX; miR-944; oral squamous cell carcinoma

Mesh:

Substances:

Year:  2020        PMID: 32881231     DOI: 10.1111/odi.13626

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  12 in total

1.  LncRNA LEMD1-AS1 relieves chondrocyte inflammation by targeting miR-944/PGAP1 in osteoarthritis.

Authors:  Haitao Li; Kaihua Lian; Jianguang Mao; Fuguo Huang; Chunli Zhang; Jianguo Zang
Journal:  Cell Cycle       Date:  2022-06-10       Impact factor: 5.173

2.  LncRNA JPX Promotes Esophageal Squamous Cell Carcinoma Progression by Targeting miR-516b-5p/VEGFA Axis.

Authors:  Yi He; Rong Hua; Yang Yang; Bin Li; Xufeng Guo; Zhigang Li
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

3.  hsa_circ_0000285 facilitates thyroid cancer progression by regulating miR-127-5p/CDH2.

Authors:  Bowei Zhang; Qiaoling Li; Zhe Song; Li Ren; Yi Gu; Chao Feng; Jinju Wang; Tong Liu
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

Review 4.  Long Non-Coding RNA (lncRNA) in Oral Squamous Cell Carcinoma: Biological Function and Clinical Application.

Authors:  Jianfei Tang; Xiaodan Fang; Juan Chen; Haixia Zhang; Zhangui Tang
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

5.  Anticancer effects of melatonin via regulating lncRNA JPX-Wnt/β-catenin signalling pathway in human osteosarcoma cells.

Authors:  Yuan Li; Jilong Zou; Bo Li; Jianyang Du
Journal:  J Cell Mol Med       Date:  2021-09-21       Impact factor: 5.310

6.  Long non-coding RNA CASC9 promotes tumor progression in oral squamous cell carcinoma by regulating microRNA-545-3p/laminin subunit gamma 2.

Authors:  Baoshan Ning; Songya Guo; Yine Mei
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 7.  Novel Insights into miR-944 in Cancer.

Authors:  Jinze Shen; Qurui Wang; Chenhao Liang; Xinming Su; Yufei Ke; Yunan Mao; Jie Fang; Shiwei Duan
Journal:  Cancers (Basel)       Date:  2022-08-31       Impact factor: 6.575

Review 8.  Unravelling the roles of Autophagy in OSCC: A renewed perspective from mechanisms to potential applications.

Authors:  Qiutong Gou; Ling-Li Zheng; Haixia Huang
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

Review 9.  Long Non-Coding RNAs as Functional Codes for Oral Cancer: Translational Potential, Progress and Promises.

Authors:  Cing-Syuan Lei; Hsing-Jien Kung; Jing-Wen Shih
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

Review 10.  The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation.

Authors:  Chiara Siniscalchi; Armando Di Palo; Aniello Russo; Nicoletta Potenza
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.